As obesity rates rise in the U.S. and worldwide, new weight-loss drugs surge in popularity
Last year, Ozempic, Rybelsus and Wegovy had combined sales of about $21.1 billion globally – up 89% since 2022.
Differing views on benefits and risks of organic foods and GMOs as Americans report higher priority for healthy eating
TOPIC
FORMAT
AUTHOR
RESEARCH AREA
Copyright 2024 Pew Research Center